CLINICAL TRIAL AGREEMENT BETWEEN THE DIVISION OF MICROBIOLOGY AND INFECTIOUS DISEASES THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (DMID/NIAID) AND Humanigen, Inc Regarding DMID Protocol # 20-0013 HGEN-003-009 Entitled “A Multicenter...Clinical Trial Agreement • July 30th, 2020 • Humanigen, Inc • Pharmaceutical preparations • District of Columbia
This Clinical Trial will be conducted at multiple sites through existing contracts and grants sponsored by NIAID. The NIAID will serve as the Investigational New Drug application (IND) Sponsor. NIAID’s contractors, grantees, research networks, clinical research sites, or their investigators are not parties to this Agreement.
